The FTC is attacking drugmakers’ ‘patent thickets’

The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices.

A roadmap for understanding antimalarial drug resistance

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer

November 29, 2024

FDA’s Janet Woodcock to retire early next year

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through

November 16, 2023

J&J shutters PhIII trial for pulmonary hypertension drug, blocking its expanded use as patent expiry looms

Johnson & Johnson has crossed off a Phase III trial from its plans, which was designed to expand the use of hypertension drug Opsumit after

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.